Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Thoracic Surgery

Free Subscription Articles published in J Heart Lung Transplant Retrieve available abstracts of 267 articles: HTML format

Single Articles

October 2025
1. LECLERC A, Danner-Boucher I, Walencik A, Guyomarch B, et al
   Pregnancy after lung transplantation: TRIGGER study on anti-human leucocyte antigen alloimmunization and antibody-mediated rejection risk.
   J Heart Lung Transplant. 2025 Oct 8:S1053-2498(25)02312.
   PubMed     Abstract available
   
   
   
2. FERNANDEZ R, Ius F, Reyes JEM, de Manna ND, et al
   Outcomes of Central versus Peripheral Arterial Cannulation for Intraoperative Extracorporeal Membrane Oxygenation Support in Lung Transplantation.
   J Heart Lung Transplant. 2025 Oct 8:S1053-2498(25)02310.
   PubMed     Abstract available
   
   
   
3. HAYES D JR,, Avdimiretz N, Brugha R, Mullen MP, et al
   International Society for Heart and Lung Transplantation Consensus Statement on the Referral and Selection of Pediatric Lung Transplant Candidates.
   J Heart Lung Transplant. 2025 Oct 8:S1053-2498(25)02199.
   PubMed     Abstract available
   
   
   
4. TSUANG WM, Neely ML, Singer LG, Belperio JA, et al
   Timing of quality of life and lung function changes during the first year following lung transplantation: a multi-center prospective cohort study.
   J Heart Lung Transplant. 2025 Oct 7:S1053-2498(25)02307.
   PubMed     Abstract available
   
   
   
5. DARIE AM, Doi A, Levvey BJ, Shingles H, et al
   Lung transplantation for chronic thromboembolic pulmonary hypertension - a case series.
   J Heart Lung Transplant. 2025 Oct 7:S1053-2498(25)02305.
   PubMed     Abstract available
   
   
   
6. BRODA CR, Kearney K, Roche SL
   Enabling effective care, empowering discovery: Tackling the tough questions about advanced heart failure in adult congenital heart disease.
   J Heart Lung Transplant. 2025;44:1679-1682.
   PubMed     Abstract available
   
   
   
7. MIYAMOTO SD, Irving C, Azeka E, Adorisio R, et al
   Authors Insights on the Updated International Society for Heart and Lung Transplantation Guidelines for the Management of Pediatric Heart Failure (Update From 2014).
   J Heart Lung Transplant. 2025;44:1529-1534.
   PubMed     Abstract available
   
   
   
8. DELMAS C, Vandenbriele C, Baudry G
   Time to rethink the prioritization of IABP patients in heart allocation systems worldwide?
   J Heart Lung Transplant. 2025;44:1674-1678.
   PubMed     Abstract available
   
   
   
9. ZHOU P, Ji J, Zhang Z, Liu X, et al
   Salidroside-loaded metal-organic frameworks hydrogel to improve cardiac allograft function.
   J Heart Lung Transplant. 2025;44:1621-1634.
   PubMed     Abstract available
   
   
   
10. KANG J, Kim YH, Choi E, Seol HY, et al
    Association of Fc gamma-binding protein rs1464897604 polymorphism with bronchiolitis obliterans syndrome in lung transplant recipients.
    J Heart Lung Transplant. 2025;44:1557-1566.
    PubMed     Abstract available
    
    
    
11. HANNAN SJ, Iasella CJ, Sciullo M, Moore C, et al
    Belatacept as an alternative immunosuppressive agent for bone marrow-sparing in idiopathic pulmonary fibrosis lung transplant recipients with short telomeres.
    J Heart Lung Transplant. 2025;44:1659-1662.
    PubMed     Abstract available
    
    
    
12. KELLER MB, Newman D, Alnababteh M, Bon A, et al
    Molecular criteria for pulmonary antibody-mediated rejection are associated with an increased risk of allograft failure.
    J Heart Lung Transplant. 2025;44:1535-1542.
    PubMed     Abstract available
    
    
    September 2025
13. SKEGGS JL, Gardiner BJ
    Letermovir: an enticing new CMV prophylaxis option with growing evidence in heart and lung transplantation.
    J Heart Lung Transplant. 2025 Sep 25:S1053-2498(25)02281.
    PubMed    
    
    
    
14. MINEURA K, Tanaka S, Goda Y, Yuasa I, et al
    The effect of CTLA4-Ig on fibrotic progression in a murine model of chronic lung allograft dysfunction.
    J Heart Lung Transplant. 2025;44:1504-1509.
    PubMed     Abstract available
    
    
    
15. LERMAN JB, Marapese KD, Johnson AR, Jamieson IR, et al
    Ensuring access to novel donor heart preservation modalities.
    J Heart Lung Transplant. 2025;44:1521-1524.
    PubMed     Abstract available
    
    
    
16. BILGILI A, Williams IE, Sharaf OM, Jimenez Contreras F, et al
    Optimal pretransplant duration with HeartMate III left ventricular assist device: A contemporary analysis.
    J Heart Lung Transplant. 2025;44:1407-1417.
    PubMed     Abstract available
    
    
    
17. GRAHAM AR, Grau-Sepulveda MV, Bush Buckley EJ, Dilling DF, et al
    CD26/DPP-IV inhibitors and associations with chronic lung allograft dysfunction in a multicenter cohort.
    J Heart Lung Transplant. 2025;44:1493-1503.
    PubMed     Abstract available
    
    
    
18. BRUNET-RATNASINGHAM E, Yellamilli S, Guo R, Mohanty RP, et al
    Persistent and progressive acute lung allograft dysfunction is linked to cell compositional and transcriptional changes in small airways.
    J Heart Lung Transplant. 2025;44:1482-1492.
    PubMed     Abstract available
    
    
    
19. ZHAO Y, Liang L, McCaig A, Aujla T, et al
    Activation of PANoptosis and ferroptosis during ex vivo lung perfusion in human lungs.
    J Heart Lung Transplant. 2025;44:1469-1481.
    PubMed     Abstract available
    
    
    
20. BLUMENTHAL JA, Mabe S, Arthur D, Frankel C, et al
    Telehealth interventions to improve outcomes in lung transplant recipients: Primary results of the INSPIRE-III randomized clinical trial.
    J Heart Lung Transplant. 2025;44:1449-1459.
    PubMed     Abstract available
    
    
    
21. KOH W, Seo J, Ollberding NJ, Hayes D Jr, et al
    Impact of renal failure requiring postoperative dialysis on lung transplant outcomes: A national registry study in children.
    J Heart Lung Transplant. 2025;44:1430-1437.
    PubMed     Abstract available
    
    
    
22. YAMAMOTO H, Wilson GW, Sundby A, Zhu S, et al
    Cell-free DNA in ex-vivo lung perfusate is associated with low-quality lungs and lung transplant outcome.
    J Heart Lung Transplant. 2025;44:1438-1448.
    PubMed     Abstract available
    
    
    
23. ELLIOTT DM, Patel CB
    Signals amid the noise: Parsing dd-cfDNA and MMDx in cardiac transplant surveillance.
    J Heart Lung Transplant. 2025;44:1394-1395.
    PubMed    
    
    
    August 2025
24. ISKENDER I, Aigner C
    RAS in lung transplantation - Renin-Angiotensin System and mitochondrial protection with Angiotensin-1-7 during pulmonary preservation at 10 degrees C.
    J Heart Lung Transplant. 2025 Aug 19:S1053-2498(25)02208.
    PubMed    
    
    
    
25. SAHAY S, Visovatti S, Tonelli AR, Villasmil Hernandez N, et al
    International Society for Heart and Lung Transplantation (ISHLT) Consensus Statement on Risk Stratification in Pulmonary Arterial Hypertension.
    J Heart Lung Transplant. 2025 Aug 18:S1053-2498(25)01951.
    PubMed    
    
    
    
26. WARE LB, Koyama T, Shaver CM, Swain S, et al
    A randomized trial of open lung protective ventilation compared to conventional mechanical ventilation in deceased organ donors.
    J Heart Lung Transplant. 2025;44:1251-1259.
    PubMed     Abstract available
    
    
    
27. WILLIAMS LJL, Hogg R, Roque MAR, Beale S, et al
    The United Kingdom's experience of controlled donation after circulatory death direct procurement of lungs with concomitant abdominal normothermic regional perfusion with an analysis of short-term outcomes.
    J Heart Lung Transplant. 2025;44:1307-1318.
    PubMed     Abstract available
    
    
    
28. SHARMA G, Vela RJ, Powell L, Deja S, et al
    Metabolic and transcriptomic insights into temperature controlled hypothermic preservation of human donor hearts.
    J Heart Lung Transplant. 2025;44:1276-1287.
    PubMed     Abstract available
    
    
    
29. HO FY, Wang X, Schaubel DE, Biscotti M 3rd, et al
    Heart donation and transplant recipient survival outcomes from deceased organ donors managed in hospital-based vs independent donor care units.
    J Heart Lung Transplant. 2025;44:1225-1236.
    PubMed     Abstract available
    
    
    
30. AMANCHERLA K, Schlendorf KH, Chow N, Sheng Q, et al
    Single-cell RNA-sequencing identifies unique cell-specific gene expression profiles in high-grade cardiac allograft vasculopathy.
    J Heart Lung Transplant. 2025;44:1321-1330.
    PubMed     Abstract available
    
    
    
31. KOBASHIGAWA J, Zuckermann A, Zeevi A, Barten MJ, et al
    The Authors' Perspective on 'Summary of the International Society for Heart and Lung Transplantation Consensus Conference on Emerging Understanding of Antibodies and Antibody-mediated Rejection in Heart Transplantation'.
    J Heart Lung Transplant. 2025;44:1195-1198.
    PubMed    
    
    
    July 2025
32. OLIVEIRA P, Wang A, Yamanashi K, Zhang Y, et al
    Angiotensin-(1-7) preconditioning during 10 degrees C static preservation improves early post-transplant graft function in a rat lung transplantation model.
    J Heart Lung Transplant. 2025 Jul 30:S1053-2498(25)02144.
    PubMed     Abstract available
    
    
    
33. GOTTLIEB J, Golpon H
    Editorial: Yes: Rethinking Lung Transplantation in the Face of Suspicion.
    J Heart Lung Transplant. 2025 Jul 25:S1053-2498(25)02145.
    PubMed    
    
    
    
34. HAYES D, Budev MM, McGiffin DC
    Combined heart-lung transplantation: Options for increasing the donor pool.
    J Heart Lung Transplant. 2025 Jul 19:S1053-2498(25)02108.
    PubMed     Abstract available
    
    
    
35. ALAM A, Golob S, Patel S, Fatma N, et al
    Consequences of Patient Denial at First Exemption Request for Cardiac Transplantation.
    J Heart Lung Transplant. 2025 Jul 19:S1053-2498(25)02063.
    PubMed    
    
    
    
36. IRVING C, Azeka E, Adorisio R, Blume ED, et al
    The International Society for Heart and Lung Transplantation Guidelines for the Management of Pediatric Heart Failure (Update From 2014).
    J Heart Lung Transplant. 2025 Jul 17:S1053-2498(25)02030.
    PubMed     Abstract available
    
    
    
37. VAZQUEZ-GUILLAMET R, Yusen RD
    Natural History of Lung Function after Lung Transplantation; from ALAD to BLAD to CLAD or Otherwise.
    J Heart Lung Transplant. 2025 Jul 12:S1053-2498(25)02103.
    PubMed    
    
    
    
38. CELIK A, Lindstedt S, McGiffin DC, Suen JY, et al
    Revitalizing Donor Organs: The Potential of Mitochondrial Transplantation in Heart and Lung Transplantation.
    J Heart Lung Transplant. 2025 Jul 5:S1053-2498(25)02107.
    PubMed     Abstract available
    
    
    
39. WAYDA B, Luikart H, Weng Y, Zhang S, et al
    Reasons for donor heart offer refusal in the United States: Results from 14,132 transplant clinician surveys in the Donor Heart Study.
    J Heart Lung Transplant. 2025;44:1075-1082.
    PubMed     Abstract available
    
    
    
40. RIBEIRO RVP, Altarabsheh SE, Segamanasinghe DL, Lopez-Muralles IW, et al
    Preconditioning donor lungs with lung-derived exosomes mitigates ischemia-reperfusion injury in a warm ischemia porcine DCD model.
    J Heart Lung Transplant. 2025;44:1149-1160.
    PubMed     Abstract available
    
    
    
41. RAZAVI AA, Kobashigawa J, Stotland A, Chen Q, et al
    Evaluating the mechanism of action behind controlled hypothermic preservation of donor hearts: A randomized pilot study.
    J Heart Lung Transplant. 2025;44:1137-1145.
    PubMed     Abstract available
    
    
    
42. WAYDA B, Luikart H, Weng Y, Zhang S, et al
    Reasons for donor heart offer refusal are often unrelated to the donor itself - when, why, and the "weekend effect".
    J Heart Lung Transplant. 2025;44:1066-1074.
    PubMed     Abstract available
    
    
    
43. GUZMAN-BOFARULL J, Rodenas-Alesina E, Moayedi Y, Truby L, et al
    Regional differences in primary graft dysfunction: A report from the international consortium on PGD.
    J Heart Lung Transplant. 2025;44:1052-1062.
    PubMed     Abstract available
    
    
    
44. VOSOUGHI D, Ulahannan A, Li Q, Huszti E, et al
    Humoral immunity to lung antigens early post-transplant confers risk for chronic lung allograft dysfunction.
    J Heart Lung Transplant. 2025;44:1109-1119.
    PubMed     Abstract available
    
    
    
45. PYA Y, Bekbossynova M, Medressova A, Latremouille C, et al
    Precise monitoring of transpulmonic resistance in bridge-to-transplant patients supported by the Aeson total artificial heart.
    J Heart Lung Transplant. 2025;44:1161-1164.
    PubMed     Abstract available
    
    
    
46. ZHOU AL, Akbar AF, Rizaldi AA, Ruck JM, et al
    New kidney-after-heart allocation policy in the United States: Who would benefit from a rescue kidney?
    J Heart Lung Transplant. 2025;44:1083-1092.
    PubMed     Abstract available
    
    
    June 2025
47. KOLAITIS NA, Singer JP, Bartolome S, Chakinala MM, et al
    The landscape of referrals for lung transplantation in pulmonary arterial hypertension: a report from the Pulmonary Hypertension Association Registry.
    J Heart Lung Transplant. 2025 Jun 26:S1053-2498(25)02055.
    PubMed     Abstract available
    
    
    
48. RAYNAUD M, Belousova N, Glorion M, Hillebrand C, et al
    Trajectories of FEV(1) after lung transplantation and patient outcomes.
    J Heart Lung Transplant. 2025 Jun 24:S1053-2498(25)02036.
    PubMed     Abstract available
    
    
    
49. KOBASHIGAWA J, Zuckermann A, Zeevi A, Barten MJ, et al
    Summary of the International Society for Heart and Lung Transplantation consensus conference on emerging understanding of antibodies and antibody-mediated rejection in heart transplantation.
    J Heart Lung Transplant. 2025 Jun 11:S1053-2498(25)01775.
    PubMed     Abstract available
    
    
    
50. VAN DER HAVE O, Tran-Lundmark K, Wahlander H, Kaskinen AK, et al
    Pediatric Heart Transplantation within the Scandiatransplant Region - A Multinational Observational Study Spanning 38 years.
    J Heart Lung Transplant. 2025 Jun 5:S1053-2498(25)02024.
    PubMed     Abstract available
    
    
    
51. TIAN D, Zheng XY, Hou SL, Yu ZW, et al
    Baicalein relieves lung graft ischemia-reperfusion injury by reducing advanced glycation endproducts: From screens to mechanisms.
    J Heart Lung Transplant. 2025;44:932-947.
    PubMed     Abstract available
    
    
    
52. OTT S, Germinario L, Muller-Wirtz LM, Nersesian G, et al
    Impact of complications on survival outcomes in different temporary mechanical circulatory support techniques: A large retrospective cohort study of cardiac surgical and nonsurgical patients.
    J Heart Lung Transplant. 2025;44:880-891.
    PubMed     Abstract available
    
    
    
53. RIM JG, Hellkamp AS, Neely ML, Reynolds JM, et al
    Basiliximab induction immunosuppression and lung transplant outcomes: Propensity analysis in a multicenter cohort.
    J Heart Lung Transplant. 2025;44:950-960.
    PubMed     Abstract available
    
    
    
54. VERVOORN MT, van Tuijl S, Ballan EM, Kaffka Genaamd Dengler SE, et al
    A novel cardioprotective perfusion protocol prevents functional decline during extended normothermic ex situ heart perfusion of marginal porcine hearts.
    J Heart Lung Transplant. 2025;44:961-971.
    PubMed     Abstract available
    
    
    
55. ANTHONY SJ, Lin J, Selkirk EK, Liang M, et al
    The iPeer2Peer mentorship program for adolescent thoracic transplant recipients: An implementation-effectiveness evaluation.
    J Heart Lung Transplant. 2025;44:858-871.
    PubMed     Abstract available
    
    
    May 2025
56. ZORN E
    Revisiting Co-Stimulation Blockade in Lung Transplantation: Insights from a RAS-Type CLAD Mouse Model.
    J Heart Lung Transplant. 2025 May 28:S1053-2498(25)01976.
    PubMed    
    
    
    
57. BARANOWSKA J, Oren D, Valledor AF, Uriel M, et al
    Efficacy and Safety of Belatacept in Heart Transplant Recipients.
    J Heart Lung Transplant. 2025 May 28:S1053-2498(25)01958.
    PubMed     Abstract available
    
    
    
58. KIM D, Kim IC, Youn JC, Chang WS, et al
    Impact of Obesity on Long Term Post Heart Transplantation Outcomes.
    J Heart Lung Transplant. 2025 May 27:S1053-2498(25)01960.
    PubMed     Abstract available
    
    
    
59. CORRIS PA, Crespo MM, Vos R, Bhorade S, et al
    An open letter to the ISHLT and its global lung transplantation community.
    J Heart Lung Transplant. 2025 May 26:S1053-2498(25)01972.
    PubMed    
    
    
    
60. CRESPO-DIAZ RJ, daSilva-deAbreu AJ, Rosenbaum AN, Bernard SA, et al
    Daratumumab monotherapy as a desensitization strategy prior to cardiac transplantation.
    J Heart Lung Transplant. 2025 May 16:S1053-2498(25)00063.
    PubMed     Abstract available
    
    
    
61. VALLEDOR AF, Moeller CM, Oren D, Baranowska J, et al
    Correlation between Donor-Derived Cell-free DNA and Tissue Gene Expression in Heart Transplant Patients Undergoing for-cause Endomyocardial Biopsies.
    J Heart Lung Transplant. 2025 May 13:S1053-2498(25)01956.
    PubMed     Abstract available
    
    
    
62. BOHMER J, Wahlander H, Tran-Lundmark K, Odermarsky M, et al
    Absolute Quantification of Donor-Derived Cell-Free DNA Following Pediatric and Adult Heart Transplantation.
    J Heart Lung Transplant. 2025 May 7:S1053-2498(25)01957.
    PubMed     Abstract available
    
    
    
63. SEBRO R, Elmahdy M, Braxton A
    Longitudinal assessment of bone mineral density changes after heart transplant: Implications for DXA screening frequency.
    J Heart Lung Transplant. 2025;44:823-829.
    PubMed     Abstract available
    
    
    
64. SINGH R, Olverson G, Punu K, Makarem A, et al
    Extended duration of ex-vivo perfusion is associated with worse survival in donation after circulatory death heart recipients: A national database analysis.
    J Heart Lung Transplant. 2025;44:813-822.
    PubMed     Abstract available
    
    
    
65. DARIE AM, Levvey BJ, Shingles HV, Paraskeva MA, et al
    Impact of donor age >/=65 years on graft survival in large lung transplant cohorts.
    J Heart Lung Transplant. 2025;44:770-779.
    PubMed     Abstract available
    
    
    
66. JUNIOR ERB, Wang A, Ribeiro RVP, Beroncal EL, et al
    The combination of postmortem sevoflurane ventilation and in situ topical cooling provides improved 6 hours lung preservation in an uncontrolled DCD porcine model.
    J Heart Lung Transplant. 2025;44:780-792.
    PubMed     Abstract available
    
    
    
67. HENG EE, Krishnan A, Elde S, Garrison A, et al
    Extracorporeal membrane oxygenation as a bridge to thoracic multiorgan transplantation.
    J Heart Lung Transplant. 2025;44:793-802.
    PubMed     Abstract available
    
    
    April 2025
68. PERCH M, Hayes D Jr, Cherikh WS, Lewis A, et al
    International Experience of Donation After Circulatory Death for Lung Transplantation. A Special Report from the International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation.
    J Heart Lung Transplant. 2025 Apr 28:S1053-2498(25)01919.
    PubMed    
    
    
    
69. HSICH E, Singh TP, Cherikh WS, Lewis A, et al
    International Experience of Donation After Circulatory Death for Heart Transplantation: A Special Report from the International Society for Heart and Lung Transplantation Thoracic Organ Transplant Registry.
    J Heart Lung Transplant. 2025 Apr 25:S1053-2498(25)01916.
    PubMed    
    
    
    
70. SINGH TP, Hsich E, Cherikh WS, Perch M, et al
    The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 2025 Annual Report of Heart and Lung Transplantation.
    J Heart Lung Transplant. 2025 Apr 25:S1053-2498(25)01920.
    PubMed    
    
    
    
71. ALIABADI-ZUCKERMANN A, Osorio-Jaramillo E, Knosalla C, Gummert J, et al
    Custodiol-N Versus Custodiol(R): Results from A Prospective Noninferiority Randomised Single Blind, Multicenter Phase 3 Trial In Patients Undergoing Heart Transplantation.
    J Heart Lung Transplant. 2025 Apr 23:S1053-2498(25)01859.
    PubMed     Abstract available
    
    
    
72. ZHUANG F, Ning Y, Li C, Luo Y, et al
    Single-cell RNA Sequencing of Pig Lung Transplantation Reveals Macrophage Ferroptosis in Lung IschemiaReperfusion Injury.
    J Heart Lung Transplant. 2025 Apr 20:S1053-2498(25)01918.
    PubMed     Abstract available
    
    
    
73. ROSENKRANZ S, Ghofrani HA, Hoeper MM, Langleben D, et al
    Corrigendum to ''Safety and efficacy of riociguat in patients with pulmonary arterial hypertension and cardiometabolic comorbidities: Data from interventional clinical trials'' [The Journal of Heart and Lung Transplantation, 44 (2025) 135-146].
    J Heart Lung Transplant. 2025 Apr 9:S1053-2498(25)01764.
    PubMed    
    
    
    
74. SCHNEIDER H, Ius F, Muller C, Salman J, et al
    Paediatric Lung Transplantation for Childhood Interstitial Lung Disease: Indications and Outcome.
    J Heart Lung Transplant. 2025 Apr 8:S1053-2498(25)01899.
    PubMed     Abstract available
    
    
    
75. MARTIN AK, Mercier O, Bottiger B, Cypel M, et al
    ISHLT consensus statement on the perioperative use of ECLS in lung transplantation: Part III: Postoperative considerations.
    J Heart Lung Transplant. 2025 Apr 7:S1053-2498(25)01838.
    PubMed     Abstract available
    
    
    
76. XUE J, Jenkins R, Ruck J, Merlo C, et al
    Rescue Kidneys in Lung Transplantation: A Retrospective Analysis of Recipients Who Might Have Benefitted from a Kidney Safety Net.
    J Heart Lung Transplant. 2025 Apr 3:S1053-2498(25)01863.
    PubMed     Abstract available
    
    
    
77. EGBE AC, Miranda WR, Connolly HM, Dearani JA, et al
    Long-term outcomes of adults with congenital heart disease and 1.5 ventricle repair.
    J Heart Lung Transplant. 2025;44:511-520.
    PubMed     Abstract available
    
    
    
78. LEFKOWITZ DS, Triplett K, Schneider L, West K, et al
    A consensus-based framework for the psychosocial evaluation of pediatric candidates for cardiothoracic transplant and ventricular assist devices.
    J Heart Lung Transplant. 2025;44:487-502.
    PubMed     Abstract available
    
    
    
79. MITCHELL CB, Simmons J, Hodo CL, Neal SJ, et al
    Early Results of an Infant Model of Orthotopic Cardiac Xenotransplantation.
    J Heart Lung Transplant. 2025;44:503-510.
    PubMed     Abstract available
    
    
    
80. ALAM AH, Lee CY, Kanwar MK, Moayedi Y, et al
    Current approaches to optimize the donor heart for transplantation.
    J Heart Lung Transplant. 2025;44:672-680.
    PubMed     Abstract available
    
    
    
81. WELLER S, Li S, Masha L
    Increases in donor/recipient predicted heart mass ratios do not result in large donor right ventricles.
    J Heart Lung Transplant. 2025;44:690-692.
    PubMed     Abstract available
    
    
    
82. LU K, Bradford MC, Wang X, Liu T, et al
    The prognostic value of single and repeated >/=10% FEV(1) declines for chronic lung allograft dysfunction.
    J Heart Lung Transplant. 2025;44:681-685.
    PubMed     Abstract available
    
    
    
83. BOS S, Hunter B, McDonald D, Merces G, et al
    High-dimensional tissue profiling of immune cell responses in chronic lung allograft dysfunction.
    J Heart Lung Transplant. 2025;44:645-658.
    PubMed     Abstract available
    
    
    
84. JIMENEZ-BLANCO M, Crespo-Leiro MG, Garcia-Cosio Carmena MD, Gomez Bueno M, et al
    Donor-derived cell-free DNA as a new biomarker for cardiac allograft rejection: A prospective study (FreeDNA-CAR).
    J Heart Lung Transplant. 2025;44:560-569.
    PubMed     Abstract available
    
    
    
85. ALDERETE IS, Pontula A, Medina CK, Halpern SE, et al
    Predictors of donation after circulatory death lung utilization and allograft survival.
    J Heart Lung Transplant. 2025;44:573-582.
    PubMed     Abstract available
    
    
    
86. CASILLAN AJ, Larson EL, Zhou AL, Ruck JM, et al
    Donor sequence number is not associated with worse lung transplant outcomes regardless of transplant center case volume.
    J Heart Lung Transplant. 2025;44:585-591.
    PubMed     Abstract available
    
    
    
87. LEVY L, Moshkelgosha S, Huszti E, Wang S, et al
    Bronchoalveolar lavage cytokine-based risk stratification of clinically-stable lung transplant recipients with undefined rejection: Further insights from a follow-up investigation.
    J Heart Lung Transplant. 2025;44:634-642.
    PubMed     Abstract available
    
    
    
88. ZHOU AL, Jennings MR, Akbar AF, Ruck JM, et al
    Utilization and outcomes of nonintubated extracorporeal membrane oxygenation as a bridge to lung transplant.
    J Heart Lung Transplant. 2025;44:661-669.
    PubMed     Abstract available
    
    
    March 2025
89. TRACY KM, Harris TR, Petrovic M, Cortelli M, et al
    Lung rehabilitation using xenogeneic cross-circulation does not lead to hyperacute rejection in a human lung transplantation model.
    J Heart Lung Transplant. 2025 Mar 20:S1053-2498(25)01837.
    PubMed     Abstract available
    
    
    
90. BELL P, Kiernan J, Ramendra R, Wang S, et al
    Gastroesophageal Reflux is a Risk Factor for the Development of de novo Donor Specific Antibodies after Lung Transplantation.
    J Heart Lung Transplant. 2025 Mar 11:S1053-2498(25)01830.
    PubMed     Abstract available
    
    
    
91. BEER G, Egle M, Graf S, Segiser A, et al
    Response to hypercapnia as a tool to assess cardiac recovery in a porcine model of DCD heart transplantation.
    J Heart Lung Transplant. 2025 Mar 11:S1053-2498(25)01833.
    PubMed     Abstract available
    
    
    
92. GRAGOSSIAN A
    "A Physician Who Underwent Heart Transplant Surgery: Lessons Learned".
    J Heart Lung Transplant. 2025 Mar 5:S1053-2498(25)01772.
    PubMed     Abstract available
    
    
    
93. KADOSH BS, Patel SS, Sidhu SK, Massie AB, et al
    Waitlist mortality for patients with cardiac allograft vasculopathy under the 2018 OPTN donor heart allocation system.
    J Heart Lung Transplant. 2025;44:378-385.
    PubMed     Abstract available
    
    
    
94. NELSON NC, Wong KK, Mahoney IJ, Malik T, et al
    Lung allograft dysbiosis associates with immune response and primary graft dysfunction.
    J Heart Lung Transplant. 2025;44:422-434.
    PubMed     Abstract available
    
    
    
95. BECHET NB, Celik A, Mittendorfer M, Wang Q, et al
    Xenotransplantation of mitochondria: A novel strategy to alleviate ischemia-reperfusion injury during ex vivo lung perfusion.
    J Heart Lung Transplant. 2025;44:448-459.
    PubMed     Abstract available
    
    
    
96. MUPFUDZE TG, Hawkins CJ, Weiss S, Goff RR, et al
    Factors associated with waitlist clinical deterioration among United States lung transplant recipients under the continuous distribution system.
    J Heart Lung Transplant. 2025;44:412-421.
    PubMed     Abstract available
    
    
    
97. BAKER WL, Moore TE, Baron E, Kittleson M, et al
    A systematic review of reporting and handling of missing data in observational studies using the UNOS database.
    J Heart Lung Transplant. 2025;44:462-468.
    PubMed     Abstract available
    
    
    
98. SEBRO R, Elmahdy M
    Optimized surveillance frequency for low bone mineral density (BMD) screening using dual-energy X-ray absorptiometry (DXA) in patients after lung transplant.
    J Heart Lung Transplant. 2025;44:404-411.
    PubMed     Abstract available
    
    
    
99. TODD JL, Weber JM, Kelly FL, Nagler A, et al
    Identification and validation of a threshold for early posttransplant bronchoalveolar fluid hyaluronan that distinguishes lung recipients at risk for chronic lung allograft dysfunction.
    J Heart Lung Transplant. 2025;44:320-328.
    PubMed     Abstract available
    
    
    
100. COMBS MP, Walter K, Hixson H, Belloli EA, et al
     Impact of tacrolimus vs cyclosporine on chronic lung allograft dysfunction incidence and allograft survival in the International Society of Heart and Lung Transplantation registry.
     J Heart Lung Transplant. 2025;44:307-317.
     PubMed     Abstract available
     
     
     February 2025
101. KHALIEL FH, Haq MI, Alsulbud AK, Altwaijri YA, et al
     "First-In-Human" Totally Robotic Orthotopic Heart Transplant.
     J Heart Lung Transplant. 2025 Feb 25:S1053-2498(25)01770.
     PubMed     Abstract available
     
     
     
102. LEE SY, Lee HN, Koo HJ, Kim HJ, et al
     Prognostic Value of Cardiac CT-Derived RV Dysfunction in Lung Transplantation Candidates: A Single-Center Retrospective Study.
     J Heart Lung Transplant. 2025 Feb 17:S1053-2498(25)01662.
     PubMed     Abstract available
     
     
     
103. AVDIMIRETZ N, Benden C
     Living donor lobar lung transplantation in children: an impressive Japanese cohort and worldwide implications.
     J Heart Lung Transplant. 2025 Feb 12:S1053-2498(25)00072.
     PubMed    
     
     
     
104. HONG Y, Nasim U, Iyanna N, Dorken-Gallastegi A, et al
     Durable left ventricular assist device in donation after circulatory death heart transplantation.
     J Heart Lung Transplant. 2025 Feb 11:S1053-2498(25)00059.
     PubMed     Abstract available
     
     
     
105. VIETZEN H
     Reply to: Comment on "Immunomodulatory soluble HLA-G and HLA-E are associated with rapidly deteriorating CLAD and HCMV viremia after lung transplantation".
     J Heart Lung Transplant. 2025 Feb 10:S1053-2498(25)00068.
     PubMed    
     
     
     
106. VANLUYTEN C, Schoenaers C, Novysedlak R, Slambrouck JV, et al
     Octo- and nonagenarian donors in lung transplantation: a dual center experience.
     J Heart Lung Transplant. 2025 Feb 10:S1053-2498(25)00070.
     PubMed     Abstract available
     
     
     
107. BRUGIERE O, Dreyfuss D, Rong S, LeMaoult J, et al
     Comment on "Immunomodulatory soluble HLA-G and HLA-E are associated with rapidly deteriorating CLAD and HCMV viremia after lung transplantation".
     J Heart Lung Transplant. 2025 Feb 7:S1053-2498(25)00015.
     PubMed    
     
     
     
108. CUSI V, Cardenas A, Tada Y, Vaida F, et al
     Surveillance Donor-Specific Antibody and Pathologic Antibody Mediated Rejection Testing in Heart Transplant Patients in the Contemporary Era.
     J Heart Lung Transplant. 2025 Feb 4:S1053-2498(25)00061.
     PubMed     Abstract available
     
     
     
109. WILLIAMS JE, Schaefer SL, Jacobs RC, Odell DD, et al
     Ex-vivo lung perfusion: National trends and post-transplant outcomes.
     J Heart Lung Transplant. 2025;44:150-158.
     PubMed     Abstract available
     
     
     
110. HALLORAN K, Vos R, Snell G, Greenland JR, et al
     The lung transplant endobronchial biopsy: A forgotten specimen comes of age.
     J Heart Lung Transplant. 2025;44:293-297.
     PubMed     Abstract available
     
     
     
111. ROSE J, Gunsalus PR, Lehr CJ, Swiler MF, et al
     A supply-based scoring approach to account for biological disadvantages in accessing lung transplant.
     J Heart Lung Transplant. 2025;44:193-201.
     PubMed     Abstract available
     
     
     
112. PAVLISKO EN, Neely ML, Wikenheiser-Brokamp KA, Fishbein GA, et al
     Diagnostic alignment to optimize inter-rater reliability among lung transplant pathologists.
     J Heart Lung Transplant. 2025;44:173-181.
     PubMed     Abstract available
     
     
     
113. KAYE DM, Kure CE, Wallinder A, McGiffin DC, et al
     Limitations of the inotrope score use as a measure of primary graft dysfunction.
     J Heart Lung Transplant. 2025;44:289-292.
     PubMed     Abstract available
     
     
     
114. BYRNE RD, Frankel WC, Nair A, Tunuguntla H, et al
     Medium to long-term ventricular assist device support in adults with congenital heart disease.
     J Heart Lung Transplant. 2025;44:278-281.
     PubMed     Abstract available
     
     
     
115. MOLINA EJ, Goldstein D, Cantor RS, Kanwar MK, et al
     Early stroke following durable left ventricular assist device (LVAD) implantation: An analysis of the Society of Thoracic Surgeons Intermacs National Database.
     J Heart Lung Transplant. 2025;44:263-272.
     PubMed     Abstract available
     
     
     
116. VERVOORN MT, Ballan EM, Kaffka Genaamd Dengler SE, Meijborg VMF, et al
     A perspective on the added value of red blood cells during cardiac hypothermic oxygenated perfusion.
     J Heart Lung Transplant. 2025;44:285-288.
     PubMed     Abstract available
     
     
     
117. LARSON EL, Leng A, Ruck JM, Casillan AJ, et al
     Outcomes of single vs double lung retransplantation in patients with cystic fibrosis.
     J Heart Lung Transplant. 2025;44:184-190.
     PubMed     Abstract available
     
     
     January 2025
118. MORIMURA Y, Matsubara K, Tanaka S, Choshi H, et al
     Survival and functional outcomes after pediatric living-donor lobar lung transplantation and deceased-donor lung transplantation: A Japanese multicenter retrospective study.
     J Heart Lung Transplant. 2025 Jan 22:S1053-2498(25)00021.
     PubMed     Abstract available
     
     
     
119. RZEPKA AM, Tile L, Chow CW, McDonald-Blumer H, et al
     Lung transplantation and bone health: A narrative review.
     J Heart Lung Transplant. 2025 Jan 19:S1053-2498(25)00018.
     PubMed     Abstract available
     
     
     
120. BERMAN M
     Thoraco Abdominal Normothermic Regional Perfusion and Lung Transplantation - Is it a Safe Match?
     J Heart Lung Transplant. 2025 Jan 17:S1053-2498(25)00003.
     PubMed    
     
     
     
121. SPADACCIO C, Salsano A, Altarabsheh S, Castro-Varela A, et al
     Short and Long-Term Outcomes of Lung Transplantation from Brain Death vs. Circulatory Death Donors: A Meta-analysis of Comparative Studies.
     J Heart Lung Transplant. 2025 Jan 9:S1053-2498(24)02024.
     PubMed     Abstract available
     
     
     
122. TSUJI M, Patel JK, Kittleson MM, Chang DH, et al
     The outcome of restrictive cardiac allograft physiology in severe coronary allograft vasculopathy.
     J Heart Lung Transplant. 2025;44:57-63.
     PubMed     Abstract available
     
     
     
123. RENAUD-PICARD B, Moshkelgosha S, Berra G, Cheung M, et al
     Detailed cellular and spatial characterization of chronic lung allograft dysfunction using imaging mass cytometry.
     J Heart Lung Transplant. 2025;44:118-124.
     PubMed     Abstract available
     
     
     
124. TAGUE LK, Anthony H, Salama NN, Hachem RR, et al
     An integrated sampling strategy for therapeutic mycophenolic acid monitoring in lung transplant recipients.
     J Heart Lung Transplant. 2025;44:46-56.
     PubMed     Abstract available
     
     
     
125. GRAF S, Egle M, Sanz MN, Segiser A, et al
     Circulating factors, in both donor and ex-situ heart perfusion, correlate with heart recovery in a pig model of DCD.
     J Heart Lung Transplant. 2025;44:92-101.
     PubMed     Abstract available
     
     
     
126. FENG I, Kurlansky PA, Zhao Y, Patel K, et al
     Bridge to simultaneous heart-kidney transplantation via extracorporeal life support: National outcomes in the new heart allocation policy era.
     J Heart Lung Transplant. 2025;44:11-21.
     PubMed     Abstract available
     
     
     
127. LIN S, Dimarakis I, Minami E, Bakthavatsalam R, et al
     Highly sensitized patients listed for heart after liver transplantation with or without domino.
     J Heart Lung Transplant. 2025;44:125-128.
     PubMed     Abstract available
     
     
     
128. MIYAMOTO E, Vosoughi D, Wang J, Al-Refaee J, et al
     Local intragraft humoral immune responses in chronic lung allograft dysfunction.
     J Heart Lung Transplant. 2025;44:105-117.
     PubMed     Abstract available
     
     
     December 2024
129. INGLIS SS, Abbas M, Asleh R, Garmany A, et al
     Incidence and risk factors for rejection after conversion from calcineurin inhibitor to sirolimus-based immunosuppression in orthotopic heart transplant recipients.
     J Heart Lung Transplant. 2024 Dec 30:S1053-2498(24)02027.
     PubMed     Abstract available
     
     
     
130. PRASAD N, Harris E, Yuzefpolskaya M, DeFilippis EM, et al
     Can Grading of Mild Cardiac Allograft Vasculopathy be Further Refined? An angiographic and physiologic assessment of heart transplant recipients with ISHLT CAV 1.
     J Heart Lung Transplant. 2024 Dec 30:S1053-2498(24)02028.
     PubMed     Abstract available
     
     
     
131. GORRAI A, Farr M, Ohara P, Beaini H, et al
     Novel Therapeutic Agents for Cardiometabolic Risk Mitigation in Heart Transplant Recipients.
     J Heart Lung Transplant. 2024 Dec 17:S1053-2498(24)02010.
     PubMed     Abstract available
     
     
     
132. ASHER M, Iyengar A, Rekhtman D, Jiang J, et al
     Goodnight Moon: The (not so) mystical effect of folklore and superstitions on cardiac transplantation.
     J Heart Lung Transplant. 2024 Dec 13:S1053-2498(24)02017.
     PubMed     Abstract available
     
     
     
133. STEWART AG, Chambers DC
     Primary graft dysfunction, dysbiosis, and innate immune activation after lung transplantation.
     J Heart Lung Transplant. 2024 Dec 11:S1053-2498(24)02016.
     PubMed    
     
     
     
134. WRIGHT LK, Culp S, Gajarski RJ, Nandi D, et al
     Equity and center variation in listing status exceptions for pediatric heart transplant candidates since pediatric review board implementation.
     J Heart Lung Transplant. 2024 Dec 9:S1053-2498(24)01999.
     PubMed     Abstract available
     
     
     
135. SADDOUGHI SA
     Breathing New Life: Expansion of ECMO as a bridge to Lung Transplantation.
     J Heart Lung Transplant. 2024 Dec 6:S1053-2498(24)02008.
     PubMed    
     
     
     
136. PEREZ-CARRILLO L, Gonzalez-Torrent I, Gimenez-Escamilla I, Delgado-Arija M, et al
     Emerging role of circulating piRNAs in the diagnosis of heart transplant rejection.
     J Heart Lung Transplant. 2024 Dec 6:S1053-2498(24)02005.
     PubMed     Abstract available
     
     
     
137. CASCINO TM, Ling C, Likosky DS, Pagani FD, et al
     A gift of life, not immortality: Evaluation of a strategy of heart transplant listing in the older patient with advanced heart failure.
     J Heart Lung Transplant. 2024 Dec 4:S1053-2498(24)02007.
     PubMed     Abstract available
     
     
     
138. EDSTROM D, Niroomand A, Stenlo M, Broberg E, et al
     Amniotic fluid-derived mesenchymal stem cells reduce inflammation and improve lung function following transplantation in a porcine model.
     J Heart Lung Transplant. 2024;43:2018-2030.
     PubMed     Abstract available
     
     
     
139. CHOI D, North M, Ahmed M, Belousova N, et al
     Pollution exposure in the first 3 months post transplant is associated with lower baseline FEV(1) and higher CLAD risk.
     J Heart Lung Transplant. 2024;43:1987-1997.
     PubMed     Abstract available
     
     
     
140. CHABAN R, Ileka I, McGrath G, Kinoshita K, et al
     Extended survival of 9- and 10-gene-edited pig heart xenografts with ischemia minimization and CD154 costimulation blockade-based immunosuppression.
     J Heart Lung Transplant. 2024;43:1932-1944.
     PubMed     Abstract available
     
     
     
141. MITTENDORFER M, Pierre L, Huzevka T, Schofield J, et al
     Restoring discarded porcine lungs by ex vivo removal of neutrophil extracellular traps.
     J Heart Lung Transplant. 2024;43:1919-1929.
     PubMed     Abstract available
     
     
     
142. CLOTHIER JS, Kobsa S, Praeger J, Bojko M, et al
     The double barrel Impella exchange: A reliable method for uninterrupted mechanical circulatory support.
     J Heart Lung Transplant. 2024;43:2031-2035.
     PubMed     Abstract available
     
     
     
143. SAKANOUE I, Okamoto T, Ayyat KS, Yun JJ, et al
     Real-time lung weight measurement during clinical ex vivo lung perfusion.
     J Heart Lung Transplant. 2024;43:2008-2017.
     PubMed     Abstract available
     
     
     November 2024
144. IYANNA N, Nasim U, Dorken-Gallastegi A, Hess NR, et al
     Impact of Cardiopulmonary Resuscitation on Donation after Circulatory Death Heart Transplantation: A United Network for Organ Sharing Registry Analysis.
     J Heart Lung Transplant. 2024 Nov 27:S1053-2498(24)01970.
     PubMed     Abstract available
     
     
     
145. CHO PD, Kim ST, Zappacosta H, White JP, et al
     Severe Primary Graft Dysfunction in Heart Transplant Recipients Using Donor Hearts After Circulatory Death: United States Experience.
     J Heart Lung Transplant. 2024 Nov 27:S1053-2498(24)01972.
     PubMed     Abstract available
     
     
     
146. HALLORAN K
     Tacrolimus, cyclosporine, and lung transplantation in the "real world".
     J Heart Lung Transplant. 2024 Nov 23:S1053-2498(24)01969.
     PubMed    
     
     
     
147. VANLUYTEN C, Vos R, Ceulemans LJ
     Nr4a1: a multilevel target to overcome PGD in lung transplantation.
     J Heart Lung Transplant. 2024 Nov 20:S1053-2498(24)01954.
     PubMed    
     
     
     
148. HONG Y, Hess NR, Dorken-Gallastegi A, Nidhi Iyanna MPH, et al
     Association of agonal phase duration with heart utilization and post-transplant outcomes in donation after circulatory death heart transplantation.
     J Heart Lung Transplant. 2024 Nov 19:S1053-2498(24)01959.
     PubMed     Abstract available
     
     
     
149. MANLA Y, Chang DH, Patel J, Kanugo A, et al
     Therapeutic Plasma Exchange is Associated with Increased Survival in Heart Transplant Recipients Experiencing Severe Primary Graft Dysfunction.
     J Heart Lung Transplant. 2024 Nov 17:S1053-2498(24)01957.
     PubMed     Abstract available
     
     
     
150. PEGUES JN, Fawaz RM, Kimfon KM, Hou H, et al
     Advancing Patient-Centered Metrics for Heart Transplantation: The Role of Days Alive and Outside the Hospital.
     J Heart Lung Transplant. 2024 Nov 15:S1053-2498(24)01944.
     PubMed     Abstract available
     
     
     
151. CHOSHI H, Miyoshi K, Tanioka M, Arai H, et al
     Long Short-Term Memory Algorithm for Personalized Tacrolimus Dosing: A Simple and Effective Time Series Forecasting Approach Post-Lung Transplantation.
     J Heart Lung Transplant. 2024 Nov 5:S1053-2498(24)01934.
     PubMed     Abstract available
     
     
     
152. JERNRYD V, Stehlik J, Metzsch C, Lund LH, et al
     Donor age and ischemic time in heart transplantation -implications for organ preservation.
     J Heart Lung Transplant. 2024 Nov 2:S1053-2498(24)01927.
     PubMed     Abstract available
     
     
     
153. SIMMONDS MJ, Thamsen B, Olia SE, McNamee AP, et al
     Will blood-informed design signal the fourth generation of cardiac assist devices?
     J Heart Lung Transplant. 2024;43:1767-1770.
     PubMed     Abstract available
     
     
     
154. ETIENNE I, Kemlin D, Gemander N, Olislagers V, et al
     Persistent defect in SARS-CoV-2 humoral and cellular immunity in lung transplant recipients.
     J Heart Lung Transplant. 2024;43:1857-1860.
     PubMed     Abstract available
     
     
     
155. CONWAY J, Pidborochynski T, Ly D, Mowat L, et al
     First North American experience with the Berlin Heart EXCOR Active driver.
     J Heart Lung Transplant. 2024;43:1861-1863.
     PubMed     Abstract available
     
     
     
156. PATEL H, Dupuis L, Bacchetta M, Hernandez A, et al
     Three-year outcomes after bridge to transplantation ECMO-pre- and post-2018 UNOS revised heart allocation system.
     J Heart Lung Transplant. 2024;43:1838-1845.
     PubMed     Abstract available
     
     
     
157. MOHANTY RP, Moghbeli K, Singer JP, Calabrese DR, et al
     Small airway brush gene expression predicts chronic lung allograft dysfunction and mortality.
     J Heart Lung Transplant. 2024;43:1820-1832.
     PubMed     Abstract available
     
     
     
158. KIM IC, Starling RC, Khush K, Passano E, et al
     Ten-year follow-up cohort of the everolimus versus azathioprine multinational prospective study focusing on intravascular ultrasound findings.
     J Heart Lung Transplant. 2024;43:1788-1794.
     PubMed     Abstract available
     
     
     
159. BHOWMIK AC, Wayda B, Luikart H, Weng Y, et al
     Just a number? Donor age and (lack of) associated reasons for heart offer refusal.
     J Heart Lung Transplant. 2024;43:1833-1837.
     PubMed     Abstract available
     
     
     
160. SCHAENMAN JM, Weigt SS, Pan M, Lee JJ, et al
     Alterations in circulating measures of Th2 immune responses pre-lung transplant associates with reduced primary graft dysfunction.
     J Heart Lung Transplant. 2024;43:1869-1872.
     PubMed     Abstract available
     
     
     
161. MEDINA CK, Aykut B, Parker LE, Prabhu NK, et al
     Early Single Center Experience with an Ex Vivo Organ Care System in Pediatric Heart Transplantation.
     J Heart Lung Transplant. 2024 Nov 1:S1053-2498(24)01930.
     PubMed     Abstract available
     
     
     October 2024
162. VAN SLAMBROUCK J, Loopmans S, Prisciandaro E, Barbarossa A, et al
     The effect of rewarming ischemia on tissue transcriptome and metabolome signatures: a clinical observational study in lung transplantation.
     J Heart Lung Transplant. 2024 Oct 30:S1053-2498(24)01905.
     PubMed     Abstract available
     
     
     
163. WEINER OJF, Das M, Clayton RH, McComb JM, et al
     Sympathetic reinnervation in cardiac transplant recipients: Prevalence, time course and association with long-term survival.
     J Heart Lung Transplant. 2024 Oct 18:S1053-2498(24)01899.
     PubMed     Abstract available
     
     
     
164. MEHTA A, Goldberg J, Bagchi P, Marboe C, et al
     Pathologist Interrater Reliability and Clinical Implications of Elevated Donor-Derived Cell-Free DNA beyond Heart Transplant Rejection.
     J Heart Lung Transplant. 2024 Oct 16:S1053-2498(24)01896.
     PubMed     Abstract available
     
     
     
165. HONG Y, Hess NR, Ziegler LA, Dorken-Gallastegi A, et al
     Effects of ex vivo machine perfusion on preservation time and donor age in donation after brain death heart transplantation.
     J Heart Lung Transplant. 2024 Oct 10:S1053-2498(24)01866.
     PubMed     Abstract available
     
     
     
166. MARTIN AK, Mercier O, Fritz AV, Gelzinis TA, et al
     ISHLT consensus statement on the perioperative use of ECLS in lung transplantation: Part II: Intraoperative considerations.
     J Heart Lung Transplant. 2024 Oct 9:S1053-2498(24)01830.
     PubMed     Abstract available
     
     
     
167. TROTTIER CA, Martino A, Short MI, Rodday AM, et al
     Impact of type of mechanical circulatory support prior to transplant on post-orthotopic heart transplantation infections.
     J Heart Lung Transplant. 2024 Oct 9:S1053-2498(24)01880.
     PubMed     Abstract available
     
     
     
168. LI SS, Funamoto M, Singh R, Rabi SA, et al
     Outcomes of Donation After Circulatory Death (DCD) and Ex-Vivo Lung Perfusion (EVLP) Lung Transplantation.
     J Heart Lung Transplant. 2024 Oct 8:S1053-2498(24)01890.
     PubMed     Abstract available
     
     
     
169. KAWANA S, Okazaki M, Sakaue T, Hashimoto K, et al
     Loss of Nr4a1 ameliorates endothelial cell injury and vascular leakage in lung transplantation from circulatory-death donor.
     J Heart Lung Transplant. 2024 Oct 4:S1053-2498(24)01878.
     PubMed     Abstract available
     
     
     
170. CALABRESE DR
     Of rivers, recipients and rejection: Revelations from deep immune phenotyping of lung allograft transbronchial biopsy tissue.
     J Heart Lung Transplant. 2024;43:1665-1667.
     PubMed    
     
     
     
171. HOLLANDER SA, Chen S, Dykes J, Kaufman BD, et al
     A comprehensive, multifaceted strategy to increase pediatric donor heart utilization.
     J Heart Lung Transplant. 2024;43:1747-1755.
     PubMed     Abstract available
     
     
     
172. AKBAR AF, Zhou AL, Ruck JM, Kilic A, et al
     Utilization and outcomes of expanded criteria donors in adults with congenital heart disease.
     J Heart Lung Transplant. 2024;43:1691-1700.
     PubMed     Abstract available
     
     
     
173. BEBER SA, Moshkelgosha S, White M, Zehong G, et al
     The CD8(+) T cell content of transbronchial biopsies from patients with a first episode of clinically stable grade A1 cellular rejection is associated with future chronic lung allograft dysfunction.
     J Heart Lung Transplant. 2024;43:1654-1664.
     PubMed     Abstract available
     
     
     September 2024
174. MINASYAN A, de la Torre M, Rodriguez JR, Abularach AJ, et al
     OUTCOMES OF CONTROLLED DCDD LUNG TRANSPLANTATION AFTER THORACO-ABDOMINAL VS ABDOMINAL NORMOTHERMIC REGIONAL PERFUSION: THE SPANISH EXPERIENCE.
     J Heart Lung Transplant. 2024 Sep 30:S1053-2498(24)01870.
     PubMed     Abstract available
     
     
     
175. SIMMONDS J, Zangwill SD, Wisotzkey B, Cantor R, et al
     Mechanical Circulatory Support Early After Pediatric Heart Transplantation - an analysis from the Pediatric Heart Transplant Society.
     J Heart Lung Transplant. 2024 Sep 11:S1053-2498(24)01833.
     PubMed     Abstract available
     
     
     
176. NEUJAHR DC
     Non-Classical Class I molecules in the crosshairs as biomarkers in lung transplantation.
     J Heart Lung Transplant. 2024 Sep 10:S1053-2498(24)01834.
     PubMed    
     
     
     
177. SAKOWITZ S, Bakhtiyar SS, Mallick S, Vadlakonda A, et al
     Hospital volume does not mitigate the impact of area socioeconomic deprivation on heart transplantation outcomes.
     J Heart Lung Transplant. 2024 Sep 10:S1053-2498(24)01801.
     PubMed     Abstract available
     
     
     
178. LIM HS, Bhagra S, Berman M, Chun SK, et al
     Severe Early Graft Dysfunction Post-Heart Transplantation: Two Clinical Trajectories and Diastolic Perfusion Pressure as a Predictor of Mechanical Circulatory Support.
     J Heart Lung Transplant. 2024 Sep 9:S1053-2498(24)01829.
     PubMed     Abstract available
     
     
     
179. EVERITT MD, Pahl E, Koehl DA, Cantor RS, et al
     Clinical Outcomes After a Biopsy Diagnosis of Antibody-mediated Rejection in Pediatric Heart Transplant Recipients.
     J Heart Lung Transplant. 2024 Sep 3:S1053-2498(24)01806.
     PubMed     Abstract available
     
     
     
180. ROGERS JG
     A remembrance of Daniel R. Goldstein, MD.
     J Heart Lung Transplant. 2024;43:1369-1371.
     PubMed    
     
     
     
181. COMBS MP, Belloli EA, Gargurevich N, Flaherty KR, et al
     Results from randomized trial of pirfenidone in patients with chronic rejection (STOP-CLAD study).
     J Heart Lung Transplant. 2024;43:1468-1477.
     PubMed     Abstract available
     
     
     
182. NICKEL I, Potapov E, Sun B, Zimpfer D, et al
     Deactivation of LVAD support for myocardial recovery-surgical perspectives.
     J Heart Lung Transplant. 2024;43:1489-1500.
     PubMed     Abstract available
     
     
     
183. BAKHTIYAR SS, Maksimuk TE, Cain MT, Hoffman JRH, et al
     Comment on: Characteristics and outcomes of lung transplants performed with ex-situ lung perfusion.
     J Heart Lung Transplant. 2024;43:1525-1526.
     PubMed    
     
     
     
184. KELLER MB, Newman D, Alnababteh M, Ponor L, et al
     Extreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of disease.
     J Heart Lung Transplant. 2024;43:1374-1382.
     PubMed     Abstract available
     
     
     August 2024
185. CLERKIN KJ, Sewanan L, Griffin JM, DeFilippis E, et al
     Added Prognostic Value of Visually Estimated Coronary Artery Calcium Among Heart Transplant Recipients.
     J Heart Lung Transplant. 2024 Aug 7:S1053-2498(24)01783.
     PubMed     Abstract available
     
     
     
186. HENRICKSEN EJ, Wayda B, Teuteberg JJ, Luikart H, et al
     Trends in Heart Transplant Outcomes for Patients Over the Age of 70 Years in the United States: an Analysis of the Scientific Registry of Transplant Recipients Database.
     J Heart Lung Transplant. 2024 Aug 7:S1053-2498(24)01784.
     PubMed     Abstract available
     
     
     
187. ROSE J, Gunsalus PR, Lehr CJ, Swiler MF, et al
     A modular simulation framework for organ allocation.
     J Heart Lung Transplant. 2024;43:1326-1335.
     PubMed     Abstract available
     
     
     
188. FUMAGALLI J, Punzi V, Scaravilli V, Passamonti SM, et al
     Lung donor bronchoalveolar lavage positivity: Incidence, risk factors, and lung transplant recipients' outcome.
     J Heart Lung Transplant. 2024;43:1288-1297.
     PubMed     Abstract available
     
     
     
189. WANG D, Tediashvili G, Kim D, Hu X, et al
     Leukotriene B4: A potential mediator and biomarker for cardiac allograft vasculopathy.
     J Heart Lung Transplant. 2024;43:1336-1347.
     PubMed     Abstract available
     
     
     
190. HASSAN GF, Cohen LS, Alexander-Brett J
     IL-33: Friend or foe in transplantation?
     J Heart Lung Transplant. 2024;43:1235-1240.
     PubMed     Abstract available
     
     
     July 2024
191. PELED Y, Ducharme A, Kittleson M, Bansal N, et al
     INTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION GUIDELINES FOR THE EVALUATION AND CARE OF CARDIAC TRANSPLANT CANDIDATES-2024.
     J Heart Lung Transplant. 2024 Jul 30:S1053-2498(24)01679.
     PubMed     Abstract available
     
     
     
192. PINSINO A, Jennings DL, Ladanyi A, Duong P, et al
     Kidney Function Assessment Using Cystatin C and Serum Creatinine in Heart Transplantation Recipients: Implications for Valganciclovir Dosing.
     J Heart Lung Transplant. 2024 Jul 26:S1053-2498(24)01748.
     PubMed     Abstract available
     
     
     
193. KUHNER LM, Berger SM, Djinovic M, Furlano PL, et al
     Immunomodulatory soluble HLA-G and HLA-E are associated with rapidly deteriorating CLAD and HCMV viremia after lung transplantation.
     J Heart Lung Transplant. 2024 Jul 25:S1053-2498(24)01747.
     PubMed     Abstract available
     
     
     
194. GARAJ M, Francesconi A, Durila M, Vajter J, et al
     ECMO PRODUCES VERY RAPID CHANGES IN PRIMARY HEMOSTASIS DETECTED BY PFA- 200 DURING LUNG TRANSPLANTATION: AN OBSERVATIONAL STUDY.
     J Heart Lung Transplant. 2024 Jul 20:S1053-2498(24)01745.
     PubMed     Abstract available
     
     
     
195. BOLLANO E, Andreassen AK, Eiskjaer H, Gustafsson F, et al
     Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial.
     J Heart Lung Transplant. 2024 Jul 20:S1053-2498(24)01732.
     PubMed     Abstract available
     
     
     
196. KOYAMA T, Zhao Z, Balmes JR, Calfee CS, et al
     Long-term air pollution exposure and the risk of primary graft dysfunction after lung transplantation.
     J Heart Lung Transplant. 2024 Jul 15:S1053-2498(24)01737.
     PubMed     Abstract available
     
     
     
197. VAN HAREN E, van Vugt LK, Wijbenga N, van der Sijs H, et al
     Recurrent Treatment of Refractory Acute Cellular Rejection with Alemtuzumab after Lung Transplantation.
     J Heart Lung Transplant. 2024 Jul 13:S1053-2498(24)01738.
     PubMed     Abstract available
     
     
     
198. FEDSON S, Lavee J, Bryce K, Egan T, et al
     Ethical considerations in xenotransplantation of thoracic organs - a call for a debate on value based decisions.
     J Heart Lung Transplant. 2024;43:1033-1038.
     PubMed     Abstract available
     
     
     
199. PUGASHETTI JV, Kim JS, Combs MP, Ma SF, et al
     A multidimensional classifier to support lung transplant referral in patients with pulmonary fibrosis.
     J Heart Lung Transplant. 2024;43:1174-1182.
     PubMed     Abstract available
     
     
     
200. ZHOU AL, Akbar AF, Kilic A
     Normothermic regional perfusion in the United States: A call for improved data collection.
     J Heart Lung Transplant. 2024;43:1196-1197.
     PubMed    
     
     
     
201. YONEYAMA F, Adachi I, Dreyer WJ, Molossi S, et al
     Incidental finding and treatment of an anomalous aortic origin of the right coronary artery in a pediatric donor's heart prior to implantation.
     J Heart Lung Transplant. 2024;43:1193-1195.
     PubMed    
     
     
     
202. BELL PT, Gelman AE
     Alveolar macrophage-CD8 T cell interactions after acute lung allograft dysfunction: Insights from single-cell RNA sequencing.
     J Heart Lung Transplant. 2024;43:1087-1089.
     PubMed    
     
     
     
203. FRANZ M, Tavil S, de Manna ND, Aburahma K, et al
     Oversizing lung allografts deteriorates outcomes in patients with pulmonary fibrosis.
     J Heart Lung Transplant. 2024;43:1126-1134.
     PubMed     Abstract available
     
     
     
204. CALABRESE DR, Ekstrand CA, Yellamilli S, Singer JP, et al
     Macrophage and CD8 T cell discordance are associated with acute lung allograft dysfunction progression.
     J Heart Lung Transplant. 2024;43:1074-1086.
     PubMed     Abstract available
     
     
     
205. AVDIMIRETZ N, Benden C
     Pediatric Lung Transplantation: A New Landscape Following the Height of the COVID-19 Pandemic.
     J Heart Lung Transplant. 2024 Jul 1:S1053-2498(24)01728.
     PubMed    
     
     
     June 2024
206. SHAHANDEH N, Kim JS, Klomhaus AM, Tehrani D, et al
     Comparison of Cardiac Allograft Vasculopathy Incidence Between Simultaneous Multi-Organ and Isolated Heart Transplant Recipients in the United States.
     J Heart Lung Transplant. 2024 Jun 29:S1053-2498(24)01706.
     PubMed     Abstract available
     
     
     
207. ROGERS JG
     Ushering in the next era at Journal of Heart and Lung Transplantation.
     J Heart Lung Transplant. 2024 Jun 22:S1053-2498(24)01702.
     PubMed    
     
     
     
208. CLERMIDY H, Mercier O, Brioude G, Mordant P, et al
     Outcomes of lung transplantation for pleuroparenchymal fibroelastosis: a French multicentric retrospective study.
     J Heart Lung Transplant. 2024 Jun 21:S1053-2498(24)01701.
     PubMed     Abstract available
     
     
     
209. PRADERE P, Le Pavec J, Morisset S, Gerovasili V, et al
     Donor to recipient age matching in lung transplantation: a European experience.
     J Heart Lung Transplant. 2024 Jun 21:S1053-2498(24)01700.
     PubMed     Abstract available
     
     
     
210. HOLMSTROM EJ, Syrjala SO, Dhaygude K, Tuuminen R, et al
     Donor Plasma VEGF-A as a Biomarker for Myocardial Injury and Primary Graft Dysfunction After Heart Transplantation.
     J Heart Lung Transplant. 2024 Jun 17:S1053-2498(24)01696.
     PubMed     Abstract available
     
     
     
211. BERNAT JL, Khush KK, Shemie SD, Hartwig MG, et al
     Knowledge gaps in heart and lung donation after the circulatory determination of death: Report of a workshop of the National Heart, Lung, and Blood Institute.
     J Heart Lung Transplant. 2024;43:1021-1029.
     PubMed     Abstract available
     
     
     
212. LARSSON JE, Kristensen SL, Deis T, Warming PE, et al
     Influence of socioeconomic status on rates of advanced heart failure therapies.
     J Heart Lung Transplant. 2024;43:920-930.
     PubMed     Abstract available
     
     
     
213. ENNIS SL, Levvey BJ, Shingles HV, Lee SJ, et al
     COVID-19 infection is mild and has minimal impact on lung function in well vaccinated and widely treated lung transplant recipients.
     J Heart Lung Transplant. 2024;43:944-953.
     PubMed     Abstract available
     
     
     
214. GALLO M, Slaughter MS, Trivedi JR
     Donor heart preservation with controlled hypothermic technology: Insights into the data.
     J Heart Lung Transplant. 2024;43:1030-1031.
     PubMed    
     
     
     
215. HABERBUSCH M, Reil J, Uyanik-Unal K, Schukro C, et al
     Decoding cardiac reinnervation from cardiac autonomic markers: A mathematical model approach.
     J Heart Lung Transplant. 2024;43:985-995.
     PubMed     Abstract available
     
     
     
216. FERNANDEZ VALLEDOR A, Rubinstein G, Moeller CM, Lorenzatti D, et al
     "Durable left ventricular assist devices as a bridge to transplantation in The Old and The New World".
     J Heart Lung Transplant. 2024;43:1010-1020.
     PubMed     Abstract available
     
     
     
217. RAMENDRA R, Duong A, Zhang CYK, Huszti E, et al
     Airway pepsinogen A4 identifies lung transplant recipients with microaspiration and predicts chronic lung allograft dysfunction.
     J Heart Lung Transplant. 2024;43:973-982.
     PubMed     Abstract available
     
     
     May 2024
218. PANICKER AJ, Prokop LJ, Hacke K, Jaramillo A, et al
     Outcome-Based Risk Assessment of Non-HLA Antibodies in Heart Transplantation: A Systematic Review.
     J Heart Lung Transplant. 2024 May 23:S1053-2498(24)01683.
     PubMed     Abstract available
     
     
     
219. CHUZI S, Cabrera E, Ilonze O, Vela A, et al
     Race, substance use, and evaluation for heart transplantation: insights from a large urban medical center.
     J Heart Lung Transplant. 2024 May 17:S1053-2498(24)01682.
     PubMed     Abstract available
     
     
     
220. DESHPANDE SR, Gajarski R, Das B, Zhang W, et al
     Critical Care Therapies Pre and Post Heart Transplant and Their Impact: Analysis from The Pediatric Cardiac Critical Care Consortium.
     J Heart Lung Transplant. 2024 May 16:S1053-2498(24)01681.
     PubMed     Abstract available
     
     
     
221. GRADY KL, Dew MA, Pagani FD, Spertus JA, et al
     A Comparison of Quality-Adjusted Life Years in Older Adults after Heart Transplantation Versus Long-Term Mechanical Support: Findings From the SUSTAIN-IT study.
     J Heart Lung Transplant. 2024 May 16:S1053-2498(24)01680.
     PubMed     Abstract available
     
     
     
222. KHUSH K, Hall S, Kao A, Raval N, et al
     Surveillance with Dual Non-invasive Testing for Acute Cellular Rejection After Heart Transplantation: Outcomes from the Surveillance HeartCare Outcomes Registry (SHORE).
     J Heart Lung Transplant. 2024 May 15:S1053-2498(24)01659.
     PubMed     Abstract available
     
     
     
223. GJESDAL G, Rylance RT, Bergh N, Dellgren G, et al
     Waiting list and Post-Transplant Outcome in Sweden after National Centralization of Heart Transplant Surgery.
     J Heart Lung Transplant. 2024 May 12:S1053-2498(24)01658.
     PubMed     Abstract available
     
     
     
224. YUZEFPOLSKAYA M, Bohn B, Ladanyi A, Pinsino A, et al
     Alterations in Sarcopenia Index are Associated with Inflammation, Gut and Oral Microbiota among Heart Failure, Left Ventricular Assist Device and Heart Transplant Patients.
     J Heart Lung Transplant. 2024 May 12:S1053-2498(24)01660.
     PubMed     Abstract available
     
     
     
225. KIM HA, Yu AG, Kim NP, Iqbal MS, et al
     Lower Opportunity ZIP Code Is Associated with Worse Outcomes after Listing in Pediatric Heart Transplantation.
     J Heart Lung Transplant. 2024 May 2:S1053-2498(24)01634.
     PubMed     Abstract available
     
     
     
226. HALE ZE, Prichett L, Jandu S, Ravekes W, et al
     Sacubitril-valsartan vs ACE/ARB in pediatric heart failure: A retrospective cohort study.
     J Heart Lung Transplant. 2024;43:826-831.
     PubMed     Abstract available
     
     
     
227. NYKANEN AI, Keshavjee S, Liu M
     Creating superior lungs for transplantation with next-generation gene therapy during ex vivo lung perfusion.
     J Heart Lung Transplant. 2024;43:838-848.
     PubMed     Abstract available
     
     
     
228. CHAO BT, McInnis MC, Sage AT, Yeung JC, et al
     A radiographic score for human donor lungs on ex vivo lung perfusion predicts transplant outcomes.
     J Heart Lung Transplant. 2024;43:797-805.
     PubMed     Abstract available
     
     
     
229. HALLORAN K, Hirji A, Weinkauf J, Nagendran J, et al
     Exploring a postoperative alternative to intraoperative therapeutic plasma exchange for sensitized lung transplant recipients.
     J Heart Lung Transplant. 2024;43:859-860.
     PubMed    
     
     
     
230. HANNAN HA, Goldberg DS
     Racial and Gender Disparities in Transplantation of Hepatitis C+ Hearts and Lungs.
     J Heart Lung Transplant. 2024;43:780-786.
     PubMed     Abstract available
     
     
     April 2024
231. RENAUD-PICARD B, Berra G, Hwang D, Huszti E, et al
     Spectrum of chronic lung allograft dysfunction pathology in human lung transplantation.
     J Heart Lung Transplant. 2024 Apr 23:S1053-2498(24)01563.
     PubMed     Abstract available
     
     
     
232. ASLAM S, Cowger J, Shah P, Stosor V, et al
     The International Society of Heart and Lung Transplantation (ISHLT): 2024 infection definitions for durable and acute mechanical circulatory support devices.
     J Heart Lung Transplant. 2024 Apr 22:S1053-2498(24)01526.
     PubMed     Abstract available
     
     
     
233. BANSAL N, West LJ, Simmonds J, Urschel S, et al
     ABO-incompatible Heart Transplantation - evolution of a revolution.
     J Heart Lung Transplant. 2024 Apr 9:S1053-2498(24)01561.
     PubMed     Abstract available
     
     
     
234. MOAYEDIFAR R, Shudo Y, Kawabori M, Silvestry S, et al
     Recipient Outcomes With Extended Criteria Donors Using Advanced Heart Preservation: An Analysis of the GUARDIAN-Heart Registry.
     J Heart Lung Transplant. 2024;43:673-680.
     PubMed     Abstract available
     
     
     
235. XU Q, Elrefaei M, Taupin JL, Hitchman KMK, et al
     Chronic lung allograft dysfunction is associated with an increased number of non-HLA antibodies.
     J Heart Lung Transplant. 2024;43:663-672.
     PubMed     Abstract available
     
     
     
236. DIAMOND JM, Anderson MR, Cantu E, Clausen ES, et al
     Development and validation of primary graft dysfunction predictive algorithm for lung transplant candidates.
     J Heart Lung Transplant. 2024;43:633-641.
     PubMed     Abstract available
     
     
     March 2024
237. ZHOU AL, Rizaldi AA, Akbar AF, Ruck JM, et al
     Outcomes Following Concomitant Multi-Organ Heart Transplantation from Circulatory Death Donors: The United States Experience.
     J Heart Lung Transplant. 2024 Mar 26:S1053-2498(24)01535.
     PubMed     Abstract available
     
     
     
238. PELED Y, Afek A, Patel JK, Raanani E, et al
     Sixth monovalent XBB.1.5 vaccine elicits robust immune response against emerging SARS-CoV-2 variants in heart transplant recipients.
     J Heart Lung Transplant. 2024 Mar 22:S1053-2498(24)01537.
     PubMed     Abstract available
     
     
     
239. VINSON AJ, Zhang X, Dahhou M, Susal C, et al
     Differences in excess mortality by recipient sex after heart transplant: An Individual Patient Data Meta-Analysis.
     J Heart Lung Transplant. 2024 Mar 22:S1053-2498(24)01536.
     PubMed     Abstract available
     
     
     
240. JEON JE, Rajapaksa Y, Keshavjee S, Liu M, et al
     Applications of transcriptomics in ischemia reperfusion research in lung transplantation.
     J Heart Lung Transplant. 2024 Mar 19:S1053-2498(24)01531.
     PubMed     Abstract available
     
     
     
241. D'ALESSANDRO D, Schroder J, Meyer DM, Vidic A, et al
     Impact of Controlled Hypothermic Preservation on Outcomes Following Heart Transplantation.
     J Heart Lung Transplant. 2024 Mar 17:S1053-2498(24)01530.
     PubMed     Abstract available
     
     
     
242. DEFILIPPIS EM, Sweigart B, Khush KK, Shah P, et al
     Sex-Specific Patterns of Donor-Derived Cell-Free DNA in Heart Transplant Rejection: An Analysis from the Genomic Research Alliance for Transplantation (GRAfT).
     J Heart Lung Transplant. 2024 Mar 7:S1053-2498(24)01520.
     PubMed     Abstract available
     
     
     
243. AUERBACH SR, Arshad A, Azeka E, Cantor RS, et al
     Impact of Prolonged Ischemic Time on Pediatric Heart Transplantation Outcomes: Improved Outcomes in the Most Recent Era.
     J Heart Lung Transplant. 2024 Mar 7:S1053-2498(24)01521.
     PubMed     Abstract available
     
     
     
244. MCGIFFIN DC, Kure CE, Macdonald PS, Jansz PC, et al
     Hypothermic oxygenated perfusion (HOPE) safely and effectively extends acceptable donor heart preservation times: Results of the Australian and New Zealand trial.
     J Heart Lung Transplant. 2024;43:485-495.
     PubMed     Abstract available
     
     
     
245. MAHLE WT, Keesari R, Trachtenberg F, Newburger JW, et al
     School age and adolescent heart failure following the Norwood procedure.
     J Heart Lung Transplant. 2024;43:453-460.
     PubMed     Abstract available
     
     
     
246. LI D, Hong H, Li M, Xu X, et al
     A surgical mouse model of neonatal right ventricular outflow tract obstruction by pulmonary artery banding.
     J Heart Lung Transplant. 2024;43:496-507.
     PubMed     Abstract available
     
     
     
247. RAM S, Verleden SE, Kumar M, Bell AJ, et al
     Computed tomography-based machine learning for donor lung screening before transplantation.
     J Heart Lung Transplant. 2024;43:394-402.
     PubMed     Abstract available
     
     
     February 2024
248. KUMAR N, Fitzsimons MG, Iyer MH, Essandoh M, et al
     Vasoplegic Syndrome during Heart Transplantation: A Systematic Review and Meta-analysis.
     J Heart Lung Transplant. 2024 Feb 28:S1053-2498(24)01498.
     PubMed     Abstract available
     
     
     
249. NASIR B, Weatherald J, Ramsay T, Cypel M, et al
     Randomized Trial Of Routine Versus On-demand Intraoperative Extracorporeal Membrane Oxygenation In Lung Transplantation: A Feasibility Study.
     J Heart Lung Transplant. 2024 Feb 27:S1053-2498(24)01496.
     PubMed     Abstract available
     
     
     
250. RAN G, Wall AE, Narang N, Khush KK, et al
     Post-transplant Survival after Normothermic Regional Perfusion vs Direct Procurement and Perfusion in Donation after Circulatory Determination of Death Heart Transplantation.
     J Heart Lung Transplant. 2024 Feb 27:S1053-2498(24)01500.
     PubMed     Abstract available
     
     
     
251. MILLIGAN C, Williams RJ, Singh TP, Bastardi HJ, et al
     Impact of a Positive Crossmatch on Pediatric Heart Transplant Outcomes.
     J Heart Lung Transplant. 2024 Feb 27:S1053-2498(24)01501.
     PubMed     Abstract available
     
     
     
252. LEE DH, Usmani A, Wu R, Wicks T, et al
     Relationship Between Donor Derived Cell-Free DNA and Tissue-Based Rejection-Related Transcripts In Heart Transplantation.
     J Heart Lung Transplant. 2024 Feb 17:S1053-2498(24)00055.
     PubMed     Abstract available
     
     
     
253. VOGEL AD, Alexander VS, Brockbank KGM, Turek JW, et al
     A Future with Partial Heart Transplantation.
     J Heart Lung Transplant. 2024 Feb 16:S1053-2498(24)00054.
     PubMed     Abstract available
     
     
     
254. PROFITA EL
     The Use of Statins in Pediatric Heart Transplantation: A Call for Standardization of Care.
     J Heart Lung Transplant. 2024 Feb 4:S1053-2498(24)00034.
     PubMed    
     
     
     January 2024
255. HONG Y, Huckaby LV, Hess NR, Ziegler LA, et al
     Impact of Post-transplant Stroke and Subsequent Functional Independence on Outcomes Following Heart Transplantation Under the 2018 United States Heart Allocation System.
     J Heart Lung Transplant. 2024 Jan 18:S1053-2498(24)00014.
     PubMed     Abstract available
     
     
     
256. JAISWAL A, Kittleson M, Pillai A, Baran D, et al
     Usage of Older Donors is Associated with Higher Mortality After Heart Transplantation: A UNOS Observational Study.
     J Heart Lung Transplant. 2024 Jan 15:S1053-2498(24)00009.
     PubMed     Abstract available
     
     
     
257. WRIGHT LK, Gajarski RJ, Hayes E, Parekh H, et al
     DQB1 Antigen Matching Improves Rejection-Free Survival in Pediatric Heart Transplant Recipients.
     J Heart Lung Transplant. 2024 Jan 15:S1053-2498(24)00012.
     PubMed     Abstract available
     
     
     
258. DE CAI Y, Wu CL, Chen YP, Hu YN, et al
     Acute T cell leukemia in a stable recipient of a heart transplantation.
     J Heart Lung Transplant. 2024 Jan 3:S1053-2498(23)02202.
     PubMed    
     
     
     December 2023
259. KIKANO S, Lee S, Dodd D, Godown J, et al
     Cardiac Magnetic Resonance Assessment of Acute Rejection and Cardiac Allograft Vasculopathy in Pediatric Heart Transplant.
     J Heart Lung Transplant. 2023 Dec 21:S1053-2498(23)02175.
     PubMed     Abstract available
     
     
     
260. BHAGRA CJ, Cherikh WS, Ross H, Kittleson MM, et al
     Informing Preconception Counseling: Outcomes Among Female Heart Transplant Recipients in the ISHLT Registry.
     J Heart Lung Transplant. 2023 Dec 13:S1053-2498(23)02165.
     PubMed     Abstract available
     
     
     
261. TOWNSEND M, Khoury M, Koehl D, Kirklin JK, et al
     Uncertain benefit of statins in pediatric heart transplant recipients: A PHTS analysis.
     J Heart Lung Transplant. 2023 Dec 6:S1053-2498(23)02159.
     PubMed     Abstract available
     
     
     
262. TRUBY LK, Kwee LC, Bowles DE, Casalinova S, et al
     Metabolomic Profiling During Ex-situ Normothermic Perfusion Prior to Heart Transplantation Defines Patterns of Substrate Utilization and Correlates with Markers of Allograft Injury.
     J Heart Lung Transplant. 2023 Dec 6:S1053-2498(23)02163.
     PubMed     Abstract available
     
     
     November 2023
263. YUZEFPOLSKAYA M, Fiedler AG, Katz JN, Houston BA, et al
     Is it time to stop living in a HeartMate II world?
     J Heart Lung Transplant. 2023;42:1621-1626.
     PubMed     Abstract available
     
     
     
264. LIN S, Minami E, O'Brien KD, Leca N, et al
     Heart after liver transplantation with domino for a highly sensitized patient.
     J Heart Lung Transplant. 2023;42:1632-1634.
     PubMed    
     
     
     
265. HARRIS E, Sewanan L, Topkara VK, Fried JA, et al
     New system, old problem: Increased wait time for high-priority transplant candidates.
     J Heart Lung Transplant. 2023;42:1497-1500.
     PubMed     Abstract available
     
     
     August 2023
266. DANI A, Ahmed HF, Guzman-Gomez A, Raees MA, et al
     Impact of Size Matching on Survival Post Heart Transplant in Infants: Estimated Total Cardiac Volume Ratio Outperforms Donor-Recipient Weight Ratio.
     J Heart Lung Transplant. 2023 Aug 17:S1053-2498(23)01968.
     PubMed     Abstract available
     
     
     April 2023
267. FIEDLER AG, Klein L, DeMarco T, Kouretas P, et al
     Comment on: Detection and Management of HLA Sensitization in Candidates for Adult Heart Transplantation.
     J Heart Lung Transplant. 2023 Apr 21:S1053-2498(23)01826.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Thoracic Surgery is free of charge.